Skip to content

ALEC

Alector, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.95
+5.98%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue13.9M21.0M100.6M97.1M133.6M
Cost of Revenue—9.7M185.9M8.8M—
Gross Profit13.9M11.4M(85.4M)88.2M133.6M
Operating Expenses
R&D Expense99.1M123.1M209.2M192.1M210.4M
SG&A Expense41.2M54.0M57.4M56.7M61.0M
General & Admin Expense41.2M54.0M57.4M56.7M61.0M
Selling & Marketing Expense—————
Other Expenses—(19.9M)(207.0M)(8.8M)—
Total Operating Expenses140.3M157.2M59.6M240.0M271.5M
Cost and Expenses140.3M166.9M245.6M248.8M271.5M
Operating Income (EBIT)(126.5M)(145.8M)(145.0M)(151.7M)(137.8M)
Non-Operating
Interest Income—————
Interest Expense—————
Net Interest Income—————
Other Non-Op Income/Expense8.9M3.0M26.1M26.6M7.8M
Non-Operating Income (excl Interest)(8.9M)(3.0M)(26.1M)(26.6M)(7.8M)
EBT (Pre-Tax Income)(117.6M)(142.8M)(118.9M)(125.2M)(130.1M)
Income Tax Expense298.0K168.0K128.0K5.2M3.3M
Bottom Line
Net Income(117.9M)(142.9M)(119.0M)(130.4M)(133.3M)
Earnings from Cont. Ops(117.9M)(142.9M)(119.0M)(130.4M)(133.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(117.9M)(142.9M)(119.0M)(130.4M)(133.3M)
Per Share
Basic EPS($1.10)($1.39)($1.23)($1.56)($1.62)
Diluted EPS($1.10)($1.39)($1.23)($1.56)($1.62)
Revenue Per Share$0.12$0.20$1.04$1.16$1.62
Shares
Basic Shares Outstanding111.2M103.0M96.6M83.7M82.5M
Diluted Shares Outstanding111.2M103.0M96.6M83.7M82.5M
Profitability Metrics
EBITDA(110.9M)(133.1M)(110.1M)(116.3M)(121.6M)
D&A6.6M9.7M8.8M8.8M8.5M
EBIT(117.6M)(142.8M)(118.9M)(125.2M)(130.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026